WILMINGTON, Del., March 14 /PRNewswire-FirstCall/ -- Today AstraZeneca released the following statement in response to the appointment of a new FDA Commissioner:
"AstraZeneca applauds the appointment of Dr. Peggy Hamburg as Commissioner of the Food and Drug Administration. Dr. Hamburg will bring a wealth of experience and knowledge that will serve the agency well in these challenging times. AstraZeneca is pleased that President Obama is acting swiftly to appoint a leader with critical responsibilities for consumer protection and innovation.
"In this remarkable new age of scientific innovation, AstraZeneca stands for a strong, well-funded FDA. AstraZeneca is committed to working with Congress, the administration and the FDA to ensure the agency has the resources it needs to protect patients by effectively reviewing life-saving and enhancing medications.
"AstraZeneca is a founding member of the Alliance for a Stronger FDA, a coalition of consumer, patient, professional and research groups, industry trade associations and individuals who support increased Congressional funding for FDA."
About AstraZeneca
AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with global healthcare sales of $ 31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar healthcare business.
For more information about AstraZeneca in the US or our AZ&Me(TM) Prescription Savings programs, please visit: http://www.astrazeneca-us.com/.
